Mechanistic issues concerning cancer prevention by tea catechins

Chung S Yang1, Hong Wang

  • 1Department of Chemical Biology and Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA. csyang@rci.rutgers.edu

Insights

Green tea polyphenols, like epigallocatechin-3-gallate (EGCG), show cancer prevention potential. However, translating cell-based findings to animal and human cancer prevention requires further investigation of molecular mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Tea (Camellia sinensis) exhibits cancer preventive activities in animal models and epidemiological studies.
  • (-)-epigallocatechin-3-gallate (EGCG), a major green tea polyphenol, modulates cell signaling and metabolic pathways.
  • Proposed mechanisms include enhanced apoptosis, suppressed cell proliferation, and inhibited angiogenesis.

Purpose of the Study:

  • To critically evaluate the extrapolation of in vitro findings to in vivo mechanisms of cancer prevention.
  • To discuss the translation of animal study results to human cancer prevention strategies.
  • To address the uncertainties in linking molecular events to carcinogenesis inhibition.

Main Methods:

  • Review of cell line studies on EGCG's molecular effects.
  • Analysis of animal models demonstrating tea's cancer preventive effects.
  • Examination of epidemiological data suggesting tea's role in cancer prevention.

Main Results:

  • Cell line studies suggest EGCG influences key cellular processes relevant to cancer.
  • Significant gaps exist in confirming these molecular mechanisms in vivo.
  • The direct translation of animal findings to human cancer prevention remains challenging.

Conclusions:

  • While EGCG shows promise, its precise role in inhibiting carcinogenesis in animals and humans needs further elucidation.
  • Bridging the gap between cell-based, animal, and human studies is crucial for effective cancer prevention strategies.
  • Further research is required to validate molecular mechanisms and ensure successful translation to human health benefits.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...